Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Cancer Therapeutics and Biotherapeutics market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Cancer Therapeutics and Biotherapeuticsmarket, defines the market attractiveness level of Cancer Therapeutics and Biotherapeutics market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Cancer Therapeutics and Biotherapeutics industry, describes the types of Cancer Therapeutics and Biotherapeutics market, the applications of major players and the market size, and deeply analyzes the current situation of the global Cancer Therapeutics and Biotherapeutics market and the development prospects and opportunities of Cancer Therapeutics and Biotherapeutics industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Cancer Therapeutics and Biotherapeutics market in Chapter 13.
By Player:
Eli Lilly & Company
Sanofi
Novartis
Johnson & Johnson
Roche
AstraZeneca
Bristol-Myers Squibb
Pfizer
Merck
By Type:
Chemotherapy
Radiation Therapy
Hormone Therapy
Biotherapy
Others
By End-User:
Household
Hospital
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Cancer Therapeutics and Biotherapeutics Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Cancer Therapeutics and Biotherapeutics Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Cancer Therapeutics and Biotherapeutics Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Cancer Therapeutics and Biotherapeutics Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Cancer Therapeutics and Biotherapeutics Market Analysis and Outlook to 2022
-
7.1 Global Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.2 United States Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.3 Europe Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.4 China Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.5 Japan Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.6 India Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
-
7.7 South Korea Cancer Therapeutics and Biotherapeutics Consumption (2017-2022)
8 Region and Country-wise Cancer Therapeutics and Biotherapeutics Market Analysis and Outlook to 2028
-
8.1 Global Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.2 United States Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.3 Europe Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.4 China Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.5 Japan Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.6 India Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
-
8.7 South Korea Cancer Therapeutics and Biotherapeutics Consumption Forecast (2022-2028)
9 Global Cancer Therapeutics and Biotherapeutics Market Outlook by Types and Applications to 2022
-
9.1 Global Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
9.1.4 Global Biotherapy Consumption and Growth Rate (2017-2022)
-
9.1.5 Global Others Consumption and Growth Rate (2017-2022)
-
9.2 Global Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Household Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Hospital Consumption and Growth Rate (2017-2022)
10 Global Cancer Therapeutics and Biotherapeutics Market Outlook by Types and Applications to 2028
-
10.1 Global Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.4 Global Biotherapy Consumption Forecast and Growth Rate (2022-2028)
-
10.1.5 Global Others Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Household Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
11 Global Cancer Therapeutics and Biotherapeutics Import and Export Analysis (Top 5 Countries)
-
11.1 Global Cancer Therapeutics and Biotherapeutics Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Cancer Therapeutics and Biotherapeutics Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Cancer Therapeutics and Biotherapeutics Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Cancer Therapeutics and Biotherapeutics Market Competitive Analysis
-
14.1 Eli Lilly & Company
-
14.1.1 Eli Lilly & Company Company Details
-
14.1.2 Eli Lilly & Company Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Eli Lilly & Company Cancer Therapeutics and Biotherapeutics Product and Service
-
14.2 Sanofi
-
14.2.1 Sanofi Company Details
-
14.2.2 Sanofi Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Sanofi Cancer Therapeutics and Biotherapeutics Product and Service
-
14.3 Novartis
-
14.3.1 Novartis Company Details
-
14.3.2 Novartis Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis Cancer Therapeutics and Biotherapeutics Product and Service
-
14.4 Johnson & Johnson
-
14.4.1 Johnson & Johnson Company Details
-
14.4.2 Johnson & Johnson Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Johnson & Johnson Cancer Therapeutics and Biotherapeutics Product and Service
-
14.5 Roche
-
14.5.1 Roche Company Details
-
14.5.2 Roche Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Roche Cancer Therapeutics and Biotherapeutics Product and Service
-
14.6 AstraZeneca
-
14.6.1 AstraZeneca Company Details
-
14.6.2 AstraZeneca Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 AstraZeneca Cancer Therapeutics and Biotherapeutics Product and Service
-
14.7 Bristol-Myers Squibb
-
14.7.1 Bristol-Myers Squibb Company Details
-
14.7.2 Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutics Product and Service
-
14.8 Pfizer
-
14.8.1 Pfizer Company Details
-
14.8.2 Pfizer Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Pfizer Cancer Therapeutics and Biotherapeutics Product and Service
-
14.9 Merck
-
14.9.1 Merck Company Details
-
14.9.2 Merck Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Merck Cancer Therapeutics and Biotherapeutics Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Cancer Therapeutics and Biotherapeutics
-
Figure Cancer Therapeutics and Biotherapeutics Picture
-
Table Global Cancer Therapeutics and Biotherapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapeutics and Biotherapeutics Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Cancer Therapeutics and Biotherapeutics Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Cancer Therapeutics and Biotherapeutics Consumption by Country (2017-2022)
-
Figure United States Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Table Europe Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Figure China Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Figure Japan Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Figure India Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Figure South Korea Cancer Therapeutics and Biotherapeutics Consumption and Growth Rate (2017-2022)
-
Figure Global Cancer Therapeutics and Biotherapeutics Consumption Forecast by Country (2022-2028)
-
Figure United States Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Cancer Therapeutics and Biotherapeutics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Chemotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Radiation Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Hormone Therapy Consumption and Growth Rate (2017-2022)
-
Figure Global Biotherapy Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Household Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Chemotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Radiation Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hormone Therapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Biotherapy Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Household Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Cancer Therapeutics and Biotherapeutics Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Cancer Therapeutics and Biotherapeutics Export by Region (Top 5 Countries) (2017-2028)
-
Table Eli Lilly & Company (Foundation Year, Company Profile and etc.)
-
Table Eli Lilly & Company Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Eli Lilly & Company Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Sanofi (Foundation Year, Company Profile and etc.)
-
Table Sanofi Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Sanofi Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Novartis (Foundation Year, Company Profile and etc.)
-
Table Novartis Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Johnson & Johnson (Foundation Year, Company Profile and etc.)
-
Table Johnson & Johnson Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Johnson & Johnson Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Roche (Foundation Year, Company Profile and etc.)
-
Table Roche Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Roche Cancer Therapeutics and Biotherapeutics Product and Service
-
Table AstraZeneca (Foundation Year, Company Profile and etc.)
-
Table AstraZeneca Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table AstraZeneca Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Bristol-Myers Squibb (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Pfizer (Foundation Year, Company Profile and etc.)
-
Table Pfizer Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Cancer Therapeutics and Biotherapeutics Product and Service
-
Table Merck (Foundation Year, Company Profile and etc.)
-
Table Merck Cancer Therapeutics and Biotherapeutics Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck Cancer Therapeutics and Biotherapeutics Product and Service
-
